ArticleGeroScience2026
Association of neurofilament light chain, CXCL9, IL-6, and TNFRSF11B with intrinsic capacity in community-dwelling older adults.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Intrinsic capacity (IC) reflects multidomain functional reserve and a measurable phenotype of healthy ageing, but its biological correlates remain incompletely understood. We examined associations of neurofilament light chain (NfL), CXCL9 and inflammatory biomarkers with IC in community-dwelling older adults. We conducted a cross-sectional analysis within the Screening and Prevention of Intrinsic Capacity Decline in Elders (SPICE) programme. IC was derived from locomotion (SPPB), cognition (MoCA), psychological health (PHQ-9), and vitality (MNA-SF), rescaled to a 0-100 composite and analysed as both z scores and tertiles. NfL, CXCL9, and TNFRSF11B were measured using Olink assays, and interleukin-6 (Il-6) by electrochemiluminescence. Multivariable linear and multinomial regression models assessed associations with IC. Mediation analyses evaluated indirect effects of inflammatory biomarkers via NfL. Among 199 participants (mean age 71.9 ± 5.2 years), NfL, CXCL9, IL-6, and TNFRSF11B increased across decreasing IC tertiles. In multivariate models, only NfL remained independently associated with IC (β - 0.41, 95% CI - 0.72 to - 0.12), with attenuation of other biomarkers after NfL adjustment. Higher NfL was associated with increased likelihood of low versus high IC (RRR 6.62, 95% CI 1.84-23.76). Mediation analyses showed significant indirect effects via NfL for CXCL9 (27.6%) and TNFRSF11B (53.9%), but not IL-6. Domain-specific analyses indicated distinct biomarker associations: NfL with locomotion and psychological health, IL-6 with locomotion, CXCL9 with vitality and TNFRSF11B with cognition. NfL was significantly associated with IC and partially mediated inflammatory associations. Integrating blood-based biomarkers with IC assessment may enhance early detection of multidomain vulnerability in ageing.
Indexed as
Identifiers
42550369What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.